Platelet function analysis: A comparison of methods
International Journal of Cardiology, ISSN: 0167-5273, Vol: 145, Issue: 1, Page: 167-168
2010
- 1Citations
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Variability in response to clopidogrel has been well described, with residual platelet reactivity (RPR) after treatment in 5–44% of patients. New point-of-care (POC) devices have been developed in an attempt to identify poor responders at risk of adverse outcomes, with a view to eventually guide titration of anti-platelets. We sought to assess sensitivity/specificity of the Accumetrics VerifyNow device for measuring responsiveness to clopidogrel in patients undergoing elective PCI compared to the more specific tool: flow-cytometric analysis using VAsodilator-Stimulated Phosphoprotein (VASP). Our findings suggest that larger replication studies and standardised guidelines are required before POC devices may be routinely used in clinical practice.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S016752730901540X; http://dx.doi.org/10.1016/j.ijcard.2009.10.037; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=78049477470&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/19897259; https://linkinghub.elsevier.com/retrieve/pii/S016752730901540X
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know